NCT00124449 - Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

May 31, 2007

Study Completion Date

April 30, 2008

Conditions

Arthritis, Rheumatoid

Interventions

DRUG

Abatacept

"solution, intravenous injection, monthly, 169 days~weight based:~\<60 kg = 500 mg~60 to 100 kg = 750 mg~\>100 kg = 1 g"

DRUG

placebo

solution, intravenous injection, 0 mg, monthly, 169 days

Trial Locations (48)

Unknown

Local Institution, Huntsville

Local Institution, Mobile

Local Institution, Huntington Beach

Local Institution, Los Angeles

Local Institution, Boulder

Local Institution, Colorado Springs

Local Institution, Fort Lauderdale

Local Institution, Chicago

Local Institution, Evansville

Local Institution, New Orleans

Local Institution, Cumberland

Local Institution, Hagerstown

Local Institution, Duluth

Local Institution, Durham

Local Institution, Wilmington

Local Institution, Oklahoma City

Local Institution, Willow Grove

Local Institution, Charleston

Local Institution, Austin

Local Institution, Arlington

Local Institution, Cairns

Local Institution, Clayton

Local Institution, Malvern

Local Institution, Shenton Park

Local Institution, Brussels

Local Institution, Leuven

Local Institution, Paris

Local Institution, Strasbourg

Local Institution, Berlin

Local Institution, Dresden

Local Institution, Hamburg

Local Institution, Hanover

Local Institution, Heidelberg

Local Institution, Bari

Local Institution, Ferrara

Local Institution, Milan

Local Institution, León

Local Institution, Guadalajara

Local Institution, Morelia

Local Institution, Ponce

Local Institution, A Coruña

Local Institution, Barcelona

Local Institution, Madrid

Local Institution, Oviedo

Local Institution, Seville

Local Institution, Liverpool

Local Institution, Leeds